News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
DP World, a global leader in supply chain solutions, has launched over 100 freight forwarding offices worldwide in a bold move aimed at bolstering support for the global healthcare sector.
With a treatment for hypoparathyroidism in late-stage development and other promising drugs in Amolyt's pipeline, the $1.05 billion deal is the latest in big pharma's push into rare disease research
A huge €128 million Series B2 round by German startup Tubulis indicates that the field of antibody-drug conjugates (ADCs) in oncology continues to capture investor imaginations.